SURVEY OF CARDIOVASCULAR DISEASE AND RISK FACTOR MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS ACROSS 5 WORLD REGIONS: RESULTS FROM THE SURF-RA

被引：0
|
作者：
Semb, A. G. [1 ]
Ikdahl, E. [1 ]
Sexton, J. [1 ]
Kitas, G. [2 ]
Van Riel, P. [3 ]
Crowson, C. S. [4 ]
Graham, I. [5 ]
Rollefstad, S. [1 ]
机构：
[1] Diakonhjemmet Hosp, Oslo, Norway
[2] Russells Hall Hosp, West Midland, England
[3] Radboud Hosp, Neijmegen, Netherlands
[4] Mayo Clin, Rochester, NY USA
[5] Trinity Coll Dublin, Dublin, Ireland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3570
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0091
引用
收藏
页码：975 / 975
页数：1
相关论文
共 50 条
  • [41] Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
    Santos-Moreno, Pedro
    Castillo, Paola
    Villareal, Laura
    Pineda, Carlos
    Sandoval, Hugo
    Valencia, Omaira
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2020, 12 : 249 - 256
  • [42] HOW PERSISTANT IS HYPERTENSION IN RHEUMATOID ARTHRITIS PATIENTS ON LEFLUNOMIDE? A 5 YEAR AUDIT AND SURVEY OF CARDIOVASCULAR RISK ASSESSMENT
    Bracewell, Claire
    McKay, Neil
    Collini, Anna
    Kidd, Elizabeth
    Wright, David
    RHEUMATOLOGY, 2010, 49 : I95 - I96
  • [43] Risk factors for cardiovascular disease in rheumatoid arthritis patients from Mato Grosso do Sul
    de Deus Junior, Ramao Souza
    Ferraz, Andressa Leite
    Oesterreich, Silvia Aparecida
    Schmitz, Wanderlei Onofre
    Shinzato, Marcia Midori
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2015, 55 (06) : 493 - 500
  • [44] The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis
    Karpouzas, George
    Ramos, Virginia Pascual
    Myasoedova, Elena
    Gonzalez-Gay, Miguel Angel
    Corrales-Martinez, Alfonso
    Rantapaa-Dahlqvist, Solbritt
    Sfikakis, Petros
    Dessein, Patrick
    Tsang, Linda
    Hitchon, Carol
    El Gabalawy, Hani
    Van Riel, Piet
    Contreras Yanez, Irazu
    Colunga Pedraza, Iris Jazmin
    Galarza-Delgado, Dionicio
    Azpiri-Lopez, Jose Ramon
    Semb, Anne Grete
    Misra, Durga P.
    Durez, Patrick
    Logstrup, Brian Bridal
    Hauge, Ellen Margrethe
    Kitas, George
    Ormseth, Sarah
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2768 - 2770
  • [45] Tocilizumab and the Risk for Cardiovascular Disease Events Among Rheumatoid Arthritis Patients: A Direct Comparison in Real World Setting
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily
    Muntner, Paul M.
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [46] Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data
    Tekeoglu, Senem
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 5859 - 5868
  • [47] TOCILIZUMAB AND THE RISK FOR CARDIOVASCULAR DISEASE EVENTS AMONG RHEUMATOID ARTHRITIS PATIENTS: A DIRECT COMPARISON IN REAL WORLD SETTING
    Xie, F.
    Yun, H.
    Levitan, E.
    Muntner, P.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 145 - 146
  • [48] Risk factor management in coronary patients: results from the EUROASPIRE V survey
    Vynckier, P.
    Gevaert, S.
    Kotseva, K.
    Tokgozoglu, L.
    De Bacquer, D.
    De Smedt, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2971 - 2971
  • [49] Differential Influence of CDAI Components Based on Disease State in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort
    Keystone, Edward C.
    Movahedi, Mohammad
    Cesta, Angela
    Bombardier, Claire
    Sampalis, John
    Rampakakis, Emmanouil
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [50] Effect of Biologic Disease Modifiers (BDMARDs) on Cardiovascular Risk of Patients with Rheumatoid Arthritis (RA)-2 Years Prospective Cohort Study
    Khraishi, Majed
    Aslanov, Rana
    Doyle, Katie
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1467 - 1468
12345